ZNF221
Zinc finger protein 221
Also known as: ZN221_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UK13
- Gene
- ZNF221
- Ensembl
- ENSG00000159905
- Chromosome
- 19
- Canonical length
- 617 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear bodies
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
617 residues, UniProt reviewed canonical sequence.
>Q9UK13|ZNF221
1 MISPSLELLH SGLCKFPEVE GKMTTFKEAV TFKDVAVVFT EEELGLLDPA QRKLYRDVML
61 ENFRNLLSVG NQPFHQDTFH FLGKEKFWKM KTTSQREGNS GGKIQIEMET VPEAGPHEEW
121 SCQQIWEQIA SDLTRSQNSI RNSSQFFKEG DVPCQIEARL SISHVQQKPY RCNECKQSFS
181 DVSVFDLHQQ SHSGEKSHTC GECGKSFCYS PALHIHQRVH MGEKCYKCDV CGKEFNQSSH
241 LQTHQRVHTG EKPFKCGQCG KGFHSRSALN VHCKLHTGEK PYNCEECGKA FIHDSQLQEH
301 QRIHTGEKPF KCDICGKSFR VRSRLNRHSM VHTGEKPFRC DTCGKNFRQR SALNSHSMVH
361 IEEKPYKCEQ CGKGFICRRD FCKHQMVHTG EKPYNCKECG KTFRWSSCLL NHQQVHSGQK
421 SFKCEECGKG FYTNSRRSSH QRSHNGEKPY NCEECGKDYK RRLDLEFHQR VHTGERPYNC
481 KECGKSFGWA SCLLKHQRLH SGEKPFKCEE CGKRFTQSSQ LHSHQTCHTG EKLYKCEQCE
541 KGYNSKFNLD MHQRVHGGER PYNCKECGKS FGWASCLLKH QRLHSGEKPL KSGVWEEIYS
601 EFTASFTSVS LCGRKAILocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF221 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 2.7 nTPM
Expression across tissuesHPA
Tissue
- retina: 2.7 nTPM
- cerebellum: 2.2 nTPM
- parathyroid gland: 2.1 nTPM
- thyroid gland: 1.7 nTPM
- cerebral cortex: 1.4 nTPM
- ovary: 1.4 nTPM
Single-cell type
- cardiomyocytes: 11 nCPM
- choroid plexus epithelial cells: 8.9 nCPM
- lactotrophs: 7.3 nCPM
- fibro-adipogenic progenitors: 6.7 nCPM
- thyrotrophs: 6.7 nCPM
- somatotrophs: 6.1 nCPM
Immune cell
- NK-cell: 0.6 nTPM
- basophil: 0.3 nTPM
- memory CD4 T-cell: 0.3 nTPM
- memory CD8 T-cell: 0.3 nTPM
- myeloid DC: 0.3 nTPM
- neutrophil: 0.3 nTPM
Brain region
- cerebellum: 18 nTPM
- white matter: 15 nTPM
- pons: 12 nTPM
- thalamus: 12 nTPM
- hypothalamus: 11 nTPM
- basal ganglia: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.66
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.42
- DepMap mean gene effect
- 0.16
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF221 as an antibody target. Whether an autoantibody or antibody against ZNF221 could matter depends on whether native ZNF221 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF221 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF221 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...